PAIN TRIGGERS
Adderall shortages causing delays in medication access.
Difficulty recognizing when ADHD meds are working as intended.
App· People with severe ADHD (combined type, predominantly inattentive)Pain 7.00/10WTP 5.0/10Market 8.0/10Validation 6.0Confidence 75%Apr 18, 2026
VyvanseNormal: ADHD Med Effectiveness Symptom Tracker
No clear indicators of what 'normal' functioning feels like on Vyvanse, making it hard to know if dose is right or needs adjustment.
adhdhealthcaremedication-managementmental-healthmobile-appmonitoringproductivityself-trackingyoung-adults
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Uncertainty in recognizing if Vyvanse (or ADHD meds) is working effectively and at the right dose, lacking clear indicators of 'normal' functioning.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
New to Vyvanse!
ADHD12
New to Vyvanse!
ADHD12
first day a pretty sudden peaceful quietness and a pretty locked in feeling... haven’t noticed that feeling since
commentProbably not much help, however I was recently prescribed adderall and I found the first day a pretty sudden peaceful quietness and a pretty locked in feeling, I’ve taken it 4 times since and haven’t noticed that feeling since. Since then I’ve felt like I usually do , with just a slight bit more energy , but more calm and mellow at the same time with less hyperactive impulsive activity. To me it seems like you shouldn’t notice feeling differently and acting different, but more so noticing what you’re not doing that you normally would if that makes sense. Just my very inexperienced take lol
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
People with severe ADHD (combined type, predominantly inattentive)Young Adults On Vyvanse For A D H D
Newly medicated young adults with ADHD switching to Vyvanse or unsure about dose
Context
Determine if current Vyvanse dose is sufficient or needs adjustment by identifying signs meds are working.
Switching from Adderall to Vyvanse to avoid shortages.
Current Workarounds
Posting detailed experiences on Reddit forums seeking community validation
Waiting weeks for psychiatrist appointments to discuss dose adjustments
Switching back to Adderall despite shortages
Relying on initial 'peaceful quietness' memory without ongoing tracking
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Adderall shortages disrupt consistent treatment.
Lack of standardized signs or experiences for 'normal' on Vyvanse.
Limited access to detailed therapy for navigating medication effects.
OPPORTUNITY & VALUE
Why Now
Adderall shortages highly repeated; med effectiveness uncertainty central to post but less repeated across comments.
Value Proposition
Vyvanse-specific benchmarks from real user data, focused on 'normal' realization moments
Product Direction
Mobile app for daily symptom tracking against crowdsourced benchmarks of effective Vyvanse dosing.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$4.99/moUnlimited tracking · premium benchmarks + export
Model
Freemium mobile app subscription
WILLINGNESS TO PAY
Users actively seek therapy alternatives and post urgently about dose uncertainty; $4.99/mo is cheaper than copays and addresses repeated forum pleas for validation they currently get via free but unreliable Reddit advice.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Track symptoms for 7 days and know if your Vyvanse dose hits 'normal'.”
Mobile app for daily symptom tracking against crowdsourced benchmarks of effective Vyvanse dosing.
Core Features
Daily logging of ADHD symptoms (focus, quietness, lock-in feeling)
Comparison to anonymized user benchmarks for 'meds working'
Simple dose adjustment signals based on trends
Weekly Roadmap
1
W1-W2
Core daily symptom tracker built and self-testable.
- •Design 5 core ADHD symptom questions (focus, executive function, etc.)
- •Build local logging and basic line graph
- •iOS/Android MVP with React Native
2
W3-W4
Community benchmarks seeded with 100 synthetic/Reddit-derived data points.
- •Aggregate anonymized benchmark data from public posts
- •Add comparison overlay on user graph
- •Dose input and simple 'match %' score
3
W5
PDF export works and 20 Reddit beta users onboarded with feedback.
- •Implement psych-report PDF export
- •Add user-submitted benchmark opt-in
- •Private beta in r/ADHD with feedback form
4
W6
App store launch with first 100 downloads and Stripe premium.
- •App store submission and approvals
- •Freemium paywall with Stripe
- •Post-launch metrics dashboard + r/Vyvanse crosspost
Launch Strategy
ADHD Reddit communities (r/ADHD, r/Vyvanse), TikTok ADHD creators, shortage megathread crossposts
RISKS & ASSUMPTIONS
Top Risks
Regulatory/medical liability
Misinterpreting benchmarks as medical advice could lead to lawsuits; requires strong disclaimers and no-diagnosis positioning.
Data quality for benchmarks
Community-submitted data may be noisy or unverified, undermining trust in 'normal' comparisons without moderation.
Short-term user need
Users may only track during 1-3 month titration, leading to high churn post-stabilization.
Acquisition in crowded ADHD space
Reddit communities are saturated with free advice, requiring viral sharing to stand out.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 6/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for App founders
It sits at the intersection of "adhd", "healthcare", "medication-management", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. Opportunities in this category typically reward founders who can describe the pain in the user's own language — both because that's the basis of effective marketing, and because it's the strongest signal that the founder has done the upfront listening. The MonetScope pipeline surfaces this category alongside other app signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "VyvanseNormal: ADHD Med Effectiveness Symptom Tracker" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most app opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.